BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 19 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | – | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2015 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2014 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2014 | $4,000 | – | 1,000 | 0.0% | 0.00% | – |
Q2 2014 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q1 2014 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2013 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2013 | $3,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLG Partners LP | 18,250,000 | $50,831,000 | 1.94% |
MACKAY SHIELDS LLC | 9,117,000 | $25,277,000 | 1.35% |
Baker Brothers Advisors | 22,898,000 | $63,217,000 | 1.25% |
Amici Capital, LLC | 8,000,000 | $22,185,000 | 0.81% |
Verition Fund Management LLC | 1,075,000 | $2,981,000 | 0.55% |
Pine River Capital Management L.P. | 4,700,000 | $13,089,000 | 0.19% |
PALISADE CAPITAL MANAGEMENT, LP | 2,000,000 | $5,570,000 | 0.16% |
SYMPHONY ASSET MANAGEMENT LLC | 324,000 | $898,000 | 0.09% |
AVIVA PLC | 2,000,000 | $5,615,000 | 0.06% |
Cheyne Capital Management (UK) LLP | 2,000,000 | $74,000 | 0.05% |